You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

DEMECLOCYCLINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Demeclocycline Hydrochloride patents expire, and when can generic versions of Demeclocycline Hydrochloride launch?

Demeclocycline Hydrochloride is a drug marketed by Amneal Pharm, Barr, Epic Pharma Llc, and Impax Labs. and is included in five NDAs.

The generic ingredient in DEMECLOCYCLINE HYDROCHLORIDE is demeclocycline hydrochloride. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the demeclocycline hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Demeclocycline Hydrochloride

A generic version of DEMECLOCYCLINE HYDROCHLORIDE was approved as demeclocycline hydrochloride by AMNEAL PHARM on February 27th, 2008.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEMECLOCYCLINE HYDROCHLORIDE?
  • What are the global sales for DEMECLOCYCLINE HYDROCHLORIDE?
  • What is Average Wholesale Price for DEMECLOCYCLINE HYDROCHLORIDE?
Drug patent expirations by year for DEMECLOCYCLINE HYDROCHLORIDE
Recent Clinical Trials for DEMECLOCYCLINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Massachusetts General HospitalPhase 1
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4

See all DEMECLOCYCLINE HYDROCHLORIDE clinical trials

Pharmacology for DEMECLOCYCLINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEMECLOCYCLINE HYDROCHLORIDE

US Patents and Regulatory Information for DEMECLOCYCLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharm DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065425-001 Feb 27, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Epic Pharma Llc DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065389-002 Dec 1, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Barr DEMECLOCYCLINE HYDROCHLORIDE demeclocycline hydrochloride TABLET;ORAL 065171-002 Dec 13, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.